How was published evidence used in model-based cost-utility analysis for lung cancer?

Abstract Background Model-based cost-utility analysis (CUA) is a widely used method for evaluating the value of innovative medicines for lung cancer. However, comprehensive evidence exploring the sources of input parameters for CUA modeling is lacking. The objective of this study was to analyze the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haijing Guan, Chunping Wang, Ruowei Xiao, Ting Zhou, Wei Li, Yanan Xu, Hongting Nie, Zhigang Zhao, Sheng Han, Feng Xie
Format:	Article
Language:	English
Published:	BMC 2025-06-01
Series:	Health Economics Review
Subjects:	Economic evaluation Cost-utility analysis Sources of parameters Model transparency Lung cancer
Online Access:	https://doi.org/10.1186/s13561-025-00651-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

How was published evidence used in model-based cost-utility analysis for lung cancer?

Similar Items